Methemoglobinemia and dapsone levels in patients with leprosy
AUTOR(ES)
Vieira, Jose Luiz Fernandes, Riveira, Juan Gonzalo Bardarez, Martins, Ana de Nazaré Silva, Silva, Jorge Pereira da, Salgado, Claudio Guedes
FONTE
Brazilian Journal of Infectious Diseases
DATA DE PUBLICAÇÃO
2010-06
RESUMO
The objective of this work was to determine the methemoglobinemia and correlate with dapsone levels in multibacillary leprosy patients under leprosy multi-drug therapy. Thirty patients with laboratory and clinical diagnosis of multibacillary leprosy were enrolled. Dapsone was analyzed by high performance liquid chromatography and methemoglobinemia by spectrophotometry. The mean dapsone concentrations in male was 1.42 g/mL and in female was 2.42 g/mL. The mean methemoglobin levels in male was 3.09 µg/mL; 191%, and in female was 2.84 ± 1.67%. No correlations were seen between dapsone levels and methemoglobin in male and female patients. Our results demonstrated that the dosage of dapsone in leprosy treatment does not promote a significant methemoglobinemia.
Documentos Relacionados
- Clinical applications and methemoglobinemia induced by dapsone
- Histopathological findings in the iris of dapsone treated leprosy patients.
- In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.
- Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.
- L-arginine, a nitric oxide precursor, reduces dapsone-induced methemoglobinemia in rats